Sulindac in osteoarthrosis of the hip.
Dieppe P A, Burry H C, Grahame R, +1 more·Rheumatology and rehabilitation
Sulindac (400 mg/day) has been compared with ibuprofen (1200 mg/day) in 40 patients with osteoarthrosis of the hip, over an eight-week period, in a double-blind controlled clinical trial. The two drugs were comparable in terms of patient preference, effects on hip movements, and toxicity. Sulindac showed superior analg…